Mergers & Acquisitions ·
Lisata Therapeutics, Inc. terminated its previously announced merger agreement with Kuva Labs Inc. and Kuva…
LSTALisata Therapeutics, Inc.
Lisata Therapeutics, Inc. terminated its previously announced merger agreement with Kuva Labs Inc. and Kuva Acquisition Corp. due to the acquirer's failure to secure sufficient financing to fund the tender offer. As a result of the termination, the acquirer is obligated to pay a $2,000,000 termination fee to the Company. The Company's Board of Directors is now conducting a strategic review to explore business combinations, asset sales, or dissolution. Lisata Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutic solutions for various medical conditions.